Cargando…
Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury
INTRODUCTION: Neutrophil gelatinase-associated lipocalin (NGAL) is a promising novel biomarker that correlates with the severity and outcome of acute kidney injury (AKI). However, its prognostic utility during the late course of AKI, especially in patients that require renal replacement therapy (RRT...
Autores principales: | Kümpers, Philipp, Hafer, Carsten, Lukasz, Alexander, Lichtinghagen, Ralf, Brand, Korbinian, Fliser, Danilo, Faulhaber-Walter, Robert, Kielstein, Jan T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875521/ https://www.ncbi.nlm.nih.gov/pubmed/20122150 http://dx.doi.org/10.1186/cc8861 |
Ejemplares similares
-
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients
por: Kümpers, Philipp, et al.
Publicado: (2008) -
Plasma Neutrophil Gelatinase-Associated Lipocalin Is Useful for Predicting Mortality in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2021) -
Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016) -
Urinary neutrophil gelatinase-associated lipocalin in critically ill surgical cancer patients
por: Delfino Duarte, Pericles Almeida, et al.
Publicado: (2015) -
Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients
por: de Geus, Hilde R. H., et al.
Publicado: (2010)